CRESCENT BIOPHARMA, INC. (CBIO) — Total Assets

Annual figures by fiscal year, from SEC filings.

2013: $5.28M2014: $57.26M2015: $48.46M2016: $42.39M2017: $128.58M2018: $214.84M2019: $167.97M2020: $142.83M2021: $94.35M2022: $51.81M2023: $45.32M2024: $35.62M2025: $240.29M$240.29M
2013Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$240.29M+574.7%
2024$35.62M-21.4%
2023$45.32M-12.5%
2022$51.81M-45.1%
2021$94.35M-33.9%
2020$142.83M-15.0%
2019$167.97M-21.8%
2018$214.84M+67.1%
2017$128.58M+203.3%
2016$42.39M-12.5%
2015$48.46M-15.4%
2014$57.26M+983.8%
2013$5.28M